Quick Answer
UTAH MEDICAL PRODUCTS INC reported Diluted EPS of $3.48 per share for fiscal year 2025.
UTAH MEDICAL PRODUCTS INC Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | $3.48 | -12.1% |
| 2024 | $3.96 | -13.3% |
| 2023 | $4.57 | +1.1% |
| 2022 | $4.52 | +11.9% |
| 2021 | $4.04 | +37.4% |
| 2020 | $2.94 | -25.4% |
| 2019 | $3.94 | -20.4% |
| 2018 | $4.95 | +117.1% |
| 2017 | $2.28 | -29.2% |
| 2016 | $3.22 | +2.5% |
| 2015 | $3.14 | +4.0% |
| 2014 | $3.02 | +0.0% |
| 2013 | $3.02 | +10.2% |
| 2012 | $2.74 | +35.0% |
| 2011 | $2.03 | +23.0% |
| 2010 | $1.65 | -4.1% |
| 2009 | $1.72 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $0.82 | -19.6% | -12.8% |
| June 30, 2025 | $0.94 | -4.1% | +2.2% |
| March 31, 2025 | $0.92 | -15.6% | -9.8% |
| September 30, 2024 | $1.02 | -5.6% | +4.1% |
| June 30, 2024 | $0.98 | -14.8% | -10.1% |
| March 31, 2024 | $1.09 | -6.0% | +0.9% |
| September 30, 2023 | $1.08 | -8.5% | -6.1% |
| June 30, 2023 | $1.15 | +2.7% | -0.9% |
- UTAH MEDICAL PRODUCTS INC showed a decrease of -12.1% in Diluted EPS compared to the prior fiscal year.
- Over the 2009–2025 period, UTAH MEDICAL PRODUCTS INC’s diluted eps has grown by 102.3% (from $1.72 per share to $3.48 per share).
- The most recent figure is from UTAH MEDICAL PRODUCTS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: